Treatment Options for Blood Cancer Patients Conference

Presentation slides and audio below from the May 21, 2016 conference.
Click the red text to access slides and audio.

BMT Update: Haplo-identical Transplant
Dr. Zeina Al-MansourLoyola University Medical Center

Presentation Slides Audio

Multiple Myeloma - Is It Now a Curable Disease?
Dr. Pritesh Patel, University of Illinois Chicago Medical Center

Presentation Slides Audio

New Approaches for Transplant Patients
Dr. Linda Burns, National Marrow Donor Program/Be The Match

Presentation Slides Audio

Treatment Approaches for Low Grade Lymphomas
Dr. Parameswaran Venugopal, Rush University Medical Center

Presentation Slides Audio

The Increasing Use of Targeted Therapies
for Leukemia and Lymphoma

Dr. Shira Dinner, Robert H. Lurie Comprehensive Cancer Center
of Northwestern University

Presentation Slides Audio

Evolving Therapies for Elderly Patients with Blood Cancers
Dr. Andrew Artz, University of Chicago Hospitals

Presentation Slides Audio

CART T-Cells: New Effective Therapy
for Leukemia and Lymphoma

Dr. Patrick Stiff, Loyola University Medical Center

Presentation Slides Audio

Physician Panel: Ask the Experts Q & A

What are the benefits of clinical trials?
Dr. Patrick Stiff, Loyola University Medical Center
Dr. Linda Burns, National Marrow Donor Program/Be The Match

When would it be appropriate for a multiple myeloma patient
to have an allogeneic transplant?

Dr. Pritesh Patel, University of Illinois Chicago Medical Center

If you had CLL, 17P deletion and un-mutated and never treated, and had to start treatment now, what would you choose to do?
Dr. Parameswaran Venugopal, Rush University Medical Center
Dr. Andrew Artz, University of Chicago Hospitals

What makes a clinical trial successful,
especially in multiple myeloma?

Dr. Linda Burns, National Marrow Donor Program/Be The Match
Dr. Patrick Stiff, Loyola University Medical Center

How can a transplant be done on an outpatient basis
when the patient is stripped of an immune system?

Dr. Linda Burns, National Marrow Donor Program/Be The Match
Dr. Zeina Al-Mansour, Loyola University Medical Center

What do you do as a patient when you have two opinions about treatment that conflict?
Dr. Patrick Stiff, Loyola University Medical Center
Dr. Andrew Artz, University of Chicago Hospitals

Please discuss AML briefly.
Dr. Andrew Artz, University of Chicago Hospitals
Dr. Patrick Stiff, Loyola University Medical Center
Dr. Linda Burns, National Marrow Donor Program/Be The Match

Why does it seem like patients are given the maximum dose of a chemotherapy drug, rather than working up from a smaller dose?
Dr. Parameswaran Venugopal, Rush University Medical Center
Dr. Patrick Stiff, Loyola University Medical Center

Since I have a new immune system after transplant, do I need to get my childhood vaccinations again and if so, how soon?
Dr. Zeina Al-Mansour, Loyola University Medical Center

Is MDS hereditary?
Can medications taken for other disorders cause MDS?

Dr. Andrew Artz, University of Chicago Hospitals
Dr. Shira Dinner, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Mark your calendar for the next Treatment Options for Blood Cancer Patients Conference
in May of 2017.

The Leukemia Research Foundation is proud to present this Conference with . . .
THANK YOU to our generous supporters.
 
Stay Informed
Sign up for e-newsletters, major
events and research alerts!

191 Waukegan Road, Ste 105, Northfield, IL 60093  |  Office: 847.424.0600  |  Fax: 847.424.0606  |  Contact Us